¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡

News search results
There are '1200' news items matching your search for 'Patent'

1. Chong Kun Dang Bio obtains patent for improved process for preparing mycophenolate mofetil

Chong Kun Dang Bio recently obtained a Korean patent for ¡®improved process for preparing mycophenolate mofetil¡¯. The patented technology blo ..
 

August 24th, 2010
2. Oscotec obtains US patent for PRF-K for the prevention and treatment of periodontitis

Oscotec, a local firm engaged in bone metabolism research, recently obtained a US patent for ¡®a herbal mixture extract of Pleurotus eryngil, ..
 

August 24th, 2010
3. Daewoong obtains patent for a manufacturing method of high-purity iopromide

Daewoong Pharm recently obtained a Korean patent for ¡®a method for selective crystallization of iopromide Z isomer¡¯. The patent relates to a ..
 

August 17th, 2010
4. Patent dispute expected for the first generic version of Opalmon

Samil Pharm recently launched the first generic version of Opalmon (limaprost) tab. for the treatment of lumbar spinal stenosis. Dong-A Phar ..
 

August 17th, 2010
5. Dongkook obtains a Korean patent for voriconazole

Dongkook Pharm recently obtained a Korean patent for ¡®a method for manufacturing voriconazole using a novel intermediate¡¯. Dongkook Pharm st ..
 

July 27th, 2010
6. KFDA approved 954 prescription drugs and 182 OTC drugs in the first half of 2010

The KFDA reported that it approved a total of 2,284 drugs, including 8 new drugs, in the first half of 2010. This represented a decrease of ..
 

July 27th, 2010
7. Approval process for phase I clinical trials to be improved

The KFDA recently announced that it made a plan for strengthening competitiveness of early-stage clinical trials in Korea, and will enforce ..
 

July 27th, 2010
8. Patents for 45 original drugs to expire between 2010 and 2021

The Health Insurance Review Agency (HIRA) recently released the list of 45 original drugs which have been included into the list of health i ..
 

July 20th, 2010
9. Organon abandons patent suits against Myungmoon for tibolone

Organon Korea abandoned patent suits against Myungmoon Pharm for tibolone on June 24th, 2010. Organon Korea had filed a suit for patent infr ..
 

July 20th, 2010
10. Major pharmaceutical firms obtained about ten overseas patents in the first half of 2010

 Dongwha Pharm, Hanall Biopharma, Daewon Pharm, Chong Kun Dang, Hanmi Pharm and Ilyang Pharm obtained about ten overseas patents in the ..
 

July 20th, 2010
11. Patent dispute for a blockbuster OTC drug between Hanmi and Ahngook forecasted

Ahngook Pharm launched Anyfen (dexibuprofen) syr. in April 2010. In this connection, Hanmi Pharm sent a warning letter to Ahngook Pharm. Han ..
 

July 6th, 2010
12. Ildong obtains a patent for a novel microorganism producing teicoplanin

Ildong Pharm recently obtained a Korean patent for ¡®a novel microorganism producing teicoplanin¡¯. Teicoplanin, a glycopeptide antibiotic, sh ..
 

June 27th, 2010
13. Substance patent regarded as the strongest tool for successful entry into the Japanese market

Examiner JEONG Se-jun of the Korean Intellectual Property Office (KIPO) delivered a speech on ¡®patent strategies for inroads into the pharma ..
 

June 27th, 2010
14. NIFDS files a patent application for pharmacogenomics

The National Institute of Food and Drug Safety Evaluation (NIFDS) recently announced that it filed a patent application for a technology for ..
 

June 22nd, 2010
15. Hanall obtains a US patent for an oral formulation of human growth hormone

Hanall Biopharma recently obtained a US patent for ¡®modified growth hormones¡¯. The patent relates to modified growth hormones prepared by us ..
 

June 22nd, 2010
[1] 2 3 4 5 6 7 8 9 10
¡¡
Pharma Koreana Ltd. 14th floor, KTB Network Bldg., 826-14, Yeoksam, Kangnam-gu, Seoul135-080 ,KOREA Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com
¡¡
¡¡